PathAI

PathAI builds integrated AI and digital pathology systems intended to change how pathology labs work. The company combines computational and medical expertise, applying artificial intelligence and machine learning to diagnostic pathology, and operates with pathology labs worldwide. Its technical work spans machine learning model training and validation, cloud-native image management and precision medicine.

Central to the company's machine learning effort is a proprietary and crowd-sourced pathology network of over 450 pathologists, whose work underpins a corpus of more than 32.5 million pathology annotations used for training and validating AI models. The company's products include AISight, a cloud-native digital pathology image management platform designed to support laboratory workflows, clinical operations and research initiatives, alongside anatomic pathology solutions, clinical development solutions, and services for biopharma companies aimed at accelerating drug development.

PathAI works across healthcare, biopharma and life sciences, serving pathology labs, clinical development programmes and drug development efforts, with a presence described as global. Roles at the company touch machine learning, digital pathology imaging infrastructure and precision medicine applications, applied in close collaboration with practising pathologists.